However, intratumoral inoculation of this Salmonella strain into NY-ESO-1-negative tumors resulted in the delivery of the antigen in vivo and led to tumor regression in the presence of preexisting NY-ESO-1-specific CD8 T cells. Here, CD8A is linked to neoplasm.